| Product NDC: | 50419-759 |
| Proprietary Name: | Cipro |
| Non Proprietary Name: | ciprofloxacin |
| Active Ingredient(s): | 2 mg/mL & nbsp; ciprofloxacin |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | SOLUTION, CONCENTRATE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50419-759 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019857 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20090422 |
| Package NDC: | 50419-759-01 |
| Package Description: | 200 mL in 1 BOTTLE, PLASTIC (50419-759-01) |
| NDC Code | 50419-759-01 |
| Proprietary Name | Cipro |
| Package Description | 200 mL in 1 BOTTLE, PLASTIC (50419-759-01) |
| Product NDC | 50419-759 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ciprofloxacin |
| Dosage Form Name | SOLUTION, CONCENTRATE |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20090422 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | CIPROFLOXACIN |
| Strength Number | 2 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] |